252 related articles for article (PubMed ID: 18360035)
1. Activation of the renin-angiotensin system and chronic hypoxia of the kidney.
Nangaku M; Fujita T
Hypertens Res; 2008 Feb; 31(2):175-84. PubMed ID: 18360035
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-induced hypoxia in the kidney: functional and structural changes of the renal circulation.
Nangaku M; Inagi R; Miyata T; Fujita T
Adv Exp Med Biol; 2007; 618():85-99. PubMed ID: 18269190
[TBL] [Abstract][Full Text] [Related]
3. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.
Nangaku M
J Am Soc Nephrol; 2006 Jan; 17(1):17-25. PubMed ID: 16291837
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.
Nangaku M
Nephron Exp Nephrol; 2004; 98(1):e8-12. PubMed ID: 15361693
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
Wolf G; Ritz E
Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
[TBL] [Abstract][Full Text] [Related]
6. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics.
Fine LG; Norman JT
Kidney Int; 2008 Oct; 74(7):867-72. PubMed ID: 18633339
[TBL] [Abstract][Full Text] [Related]
7. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
Kobori H; Nangaku M; Navar LG; Nishiyama A
Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
[TBL] [Abstract][Full Text] [Related]
8. Impact of gender on the renal response to angiotensin II.
Miller JA; Anacta LA; Cattran DC
Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms in remodeling of the kidney].
Nangaku M; Miyata T
Nihon Rinsho; 2008 Sep; 66(9):1696-700. PubMed ID: 18788396
[TBL] [Abstract][Full Text] [Related]
10. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
11. The Remission Clinic approach to halt the progression of kidney disease.
;
J Nephrol; 2011; 24(3):274-81. PubMed ID: 21534237
[TBL] [Abstract][Full Text] [Related]
12. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
13. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
14. Intrarenal oxygenation in chronic renal failure.
Norman JT; Fine LG
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):989-96. PubMed ID: 17002678
[TBL] [Abstract][Full Text] [Related]
15. Impact of renin-angiotensin system blockade on structure and function of glomerular membrane components in animal models of kidney disease.
Remuzzi A; Mohamed EI
Exp Nephrol; 1996; 4 Suppl 1():27-33. PubMed ID: 9001894
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation.
Carvajal G; Rodríguez-Vita J; Rodrigues-Díez R; Sánchez-López E; Rupérez M; Cartier C; Esteban V; Ortiz A; Egido J; Mezzano SA; Ruiz-Ortega M
Kidney Int; 2008 Sep; 74(5):585-95. PubMed ID: 18509316
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure.
Nangaku M
Intern Med; 2004 Jan; 43(1):9-17. PubMed ID: 14964574
[TBL] [Abstract][Full Text] [Related]
18. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
Tikkanen I; Johnston CI
Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
[TBL] [Abstract][Full Text] [Related]
19. Role of hypoxia in the pathogenesis of renal disease.
Eckardt KU; Rosenberger C; Jürgensen JS; Wiesener MS
Blood Purif; 2003; 21(3):253-7. PubMed ID: 12784052
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II and its role in tubular epithelial to mesenchymal transition associated with chronic kidney disease.
Burns WC; Thomas MC
Cells Tissues Organs; 2011; 193(1-2):74-84. PubMed ID: 21041999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
